Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design, synthesis and biological evaluation of quinoline-2-carbonitrile-based hydroxamic acids as dual tubulin polymerization and histone deacetylases inhibitors
Camille Hauguel, Sarah Ducellier, Olivier Provot, et al.
European Journal of Medicinal Chemistry (2022) Vol. 240, pp. 114573-114573
Open Access | Times Cited: 25

Showing 25 citing articles:

Overview of the epigenetic/cytotoxic dual-target inhibitors for cancer therapy
Hailiu Liang, Shuqing Li, Xiaopeng Peng, et al.
European Journal of Medicinal Chemistry (2025) Vol. 285, pp. 117235-117235
Closed Access | Times Cited: 1
The microtubule cytoskeleton: An old validated target for novel therapeutic drugs
Laurence Lafanéchère
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 31
A Therapeutic Perspective of HDAC8 in Different Diseases: An Overview of Selective Inhibitors
Anna Fontana, Ilaria Cursaro, Gabriele Carullo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 17, pp. 10014-10014
Open Access | Times Cited: 30
Design and biological evaluation of dual tubulin/HDAC inhibitors based on millepachine for treatment of prostate cancer
S Xie, Jiafu Leng, Shifang Zhao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116301-116301
Closed Access | Times Cited: 8
Dual molecule targeting HDAC6 leads to intratumoral CD4+ cytotoxic lymphocytes recruitment through MHC-II upregulation on lung cancer cells
Sarah Ducellier, Mélanie Demeules, Boris Letribot, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e007588-e007588
Open Access | Times Cited: 6
Design, Synthesis and Mechanistic Study of New Dual Targeting HDAC/Tubulin Inhibitors
Mona S. El‐Zoghbi, Amr K. A. Bass, Gamal El‐Din A. Abuo‐Rahma, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 7, pp. 601-622
Open Access | Times Cited: 5
Nuclear to Cytoplasmic Transport Is a Druggable Dependency in HDAC7‐driven Small Cell Lung Cancer
Tingting Qin, Jingya Wang, Jian Wang, et al.
Advanced Science (2025)
Open Access
The antibreast cancer therapeutic potential of quinazoline hybrids–Part I
Wei Chen, Ruo Wang, Yidan Lin, et al.
Future Medicinal Chemistry (2025), pp. 1-15
Closed Access
Recent Advancements in the Development of HDAC/Tubulin Dual-Targeting Inhibitors
Christine Tran, Abdallah Hamzé
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 341-341
Open Access
Synthesis and bioevaluation of novel stilbene-based derivatives as tubulin/HDAC dual-target inhibitors with potent antitumor activities in vitro and in vivo
Huajian Zhu, Wenjian Zhu, Yang Liu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 257, pp. 115529-115529
Open Access | Times Cited: 9
Hydroxamic acid hybrids: Histone deacetylase inhibitors with anticancer therapeutic potency
Yuan Jiang Pan, Haodong Hou, Bo Zhou, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115879-115879
Closed Access | Times Cited: 8
Direct Z-Scheme g-C3N5/Cu3TiO4 Heterojunction Enhanced Photocatalytic Performance of Chromene-3-Carbonitriles Synthesis under Visible Light Irradiation
Murugan Arunachalapandi, Thangapandi Chellapandi, Gunabalan Madhumitha, et al.
Catalysts (2022) Vol. 12, Iss. 12, pp. 1593-1593
Open Access | Times Cited: 13
Novel combretastatin A-4 derivative containing aminophosphonates as dual inhibitors of tubulin and matrix metalloproteinases for lung cancer treatment
Xiaochao Huang, Yuanhang Chen, Wentian Zhong, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114817-114817
Closed Access | Times Cited: 12
Recent developments of hydroxamic acid hybrids as potential anti-breast cancer agents
Xinran Cao, Yufeng Gong
Future Medicinal Chemistry (2024) Vol. 16, Iss. 5, pp. 469-492
Open Access | Times Cited: 2
Pharmacophore‐Based Modeling, Synthesis, and Biological Evaluation of Novel Quinazoline/Quinoline Derivatives: Discovery of EGFR Inhibitors with Low Nanomolar Activity
Asaf Evrim Evren, Begüm Nurpelin Sağlık, Gülşen Akalın-Çiftçi, et al.
Advanced Theory and Simulations (2024)
Open Access | Times Cited: 2
Recent Development of Quinoline Derivatives as Anticancer Agents: 2015–2022
Komalpreet Kaur, Nitish Kumar, Jatinder Singh, et al.
(2023), pp. 217-250
Closed Access | Times Cited: 4
Hit Identification and Functional Validation of Novel Dual Inhibitors of HDAC8 and Tubulin Identified by Combining Docking and Molecular Dynamics Simulations
Antonio Curcio, Roberta Rocca, Federica Chiera, et al.
Antioxidants (2024) Vol. 13, Iss. 11, pp. 1427-1427
Open Access | Times Cited: 1
Design, synthesis, biological evaluation and molecular docking study of novel quinolone derivatives as potent HDAC1 (Histone Deacetylase) inhibitors and anticancer agents
Vahid Eskandarpour, Farzin Hadizadeh, Khalil Abnous, et al.
Journal of Molecular Structure (2024), pp. 141011-141011
Closed Access | Times Cited: 1
Tubulin/HDAC dual-target inhibitors: Insights from design strategies, SARs, and therapeutic potential
Zhen Zhang, Rui Su, Juan Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117022-117022
Closed Access | Times Cited: 1
The Development of HDAC and Tubulin Dual-Targeting Inhibitors for Cancer Therapy
Jing Nie, Huina Wu, Yepeng Luan, et al.
Mini-Reviews in Medicinal Chemistry (2023) Vol. 24, Iss. 5, pp. 480-490
Closed Access | Times Cited: 3
Review; Recent approaches on Tubulin Polymerization inhibitors (2018-2022)
Azhar O. El-Abd
Delta University Scientific Journal (2024) Vol. 7, Iss. 1
Open Access
Reactions of Tetracyanoethylene with Aliphatic and Aromatic Amines and Hydrazines and Chemical Transformations of Tetracyanoethylene Derivatives
Elizaveta Ivanova, Margarita Osipova, Yhtyyar Kadyrov, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4727-4727
Open Access
Dual-targeting inhibitors involving tubulin for the treatment of cancer
Prasanna Anjaneyulu Yakkala, Ähmed Kamal
Bioorganic Chemistry (2024) Vol. 156, pp. 108116-108116
Closed Access
Quantitative analysis of the effect of microtubule-targeting drugs on the microtubule cytoskeleton of breast cancer cells with different invasive properties
Sophie Michallet, Lauriane Bosc, Laurence Lafanéchère
Comptes Rendus Chimie (2023) Vol. 26, Iss. S3, pp. 1-8
Open Access
Anticancer Dual Molecule Targeting Inhibition of Tubulin Polymerization and HDAC
Dirk Trauner, Yingfang Wang
Synfacts (2022) Vol. 18, Iss. 10, pp. 1143-1143
Closed Access
Page 1

Scroll to top